Lancet Global Health最新文献

筛选
英文 中文
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care. 世卫组织推荐的晚期艾滋病毒疾病一揽子护理的临床影响和成本效益。
IF 19.9 1区 医学
Lancet Global Health Pub Date : 2025-08-01 DOI: 10.1016/S2214-109X(25)00190-1
Emily P Hyle, Thulani Maphosa, Ajay Rangaraj, Mary Feser, Geoffrey C Singini, Prakriti Shrestha, Amir Shroufi, Krishna P Reddy, Eddie Matiya, Rosalia Dambe, Virginia R Talbot, Rachel Chamanga, C Robert Horsburgh, Milton C Weinstein, Rose K Nyirenda, Nathan Ford, Appolinaire Tiam, Andrew Phillips, Kenneth A Freedberg
{"title":"Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care.","authors":"Emily P Hyle, Thulani Maphosa, Ajay Rangaraj, Mary Feser, Geoffrey C Singini, Prakriti Shrestha, Amir Shroufi, Krishna P Reddy, Eddie Matiya, Rosalia Dambe, Virginia R Talbot, Rachel Chamanga, C Robert Horsburgh, Milton C Weinstein, Rose K Nyirenda, Nathan Ford, Appolinaire Tiam, Andrew Phillips, Kenneth A Freedberg","doi":"10.1016/S2214-109X(25)00190-1","DOIUrl":"10.1016/S2214-109X(25)00190-1","url":null,"abstract":"<p><strong>Background: </strong>In sub-Saharan Africa, 20-40% of people living with HIV present with advanced HIV disease (AHD), which can be diagnosed, treated, and prevented using a package of care recommended by WHO. We aimed to project the cost-effectiveness and budget impact of the WHO-recommended AHD package in Malawi.</p><p><strong>Methods: </strong>Using the Cost-Effectiveness of Preventing AIDS Complications-International model, we simulated a cohort of non-hospitalised people living with HIV (aged >19 years) initiating antiretroviral therapy (ART), 25% of whom had AHD (CD4 count <200 cells per μL and/or WHO stage 3 or 4 disease). We assessed 13 increasingly comprehensive strategies, ranging from ART only to the WHO-recommended AHD package, including tuberculosis diagnostics (ie, sputum Xpert and urine lipoarabinomannan), tuberculosis preventive therapy, serum cryptococcal antigen (CrAg) screening with pre-emptive fluconazole treatment if CrAg-positive, and co-trimoxazole to prevent bacterial infections. Model outcomes included 1 year survival, life expectancy, costs, and incremental cost-effectiveness ratios (ICERs, US$ per quality-adjusted life-year [QALY]); we considered a strategy cost-effective if the ICER was less than $600 per QALY (based on 2023 Malawi per capita gross domestic product).</p><p><strong>Findings: </strong>ART only resulted in life expectancy of 17·45 undiscounted QALYs and discounted lifetime costs of $1450. All other strategies would increase both QALYs and costs. The WHO-recommended AHD package would result in the greatest life expectancy (19·30 undiscounted QALYs) and be cost-effective (ICER $580 per QALY). AHD prevalence and intervention efficacy had the greatest influence on ICERs; however, the WHO-recommended AHD package would remain cost-effective over a wide range of estimates.</p><p><strong>Interpretation: </strong>The WHO-recommended AHD package of care at ART initiation would provide substantial clinical benefits and be cost-effective in Malawi. This package for AHD should be made widely available in Malawi and similar settings.</p><p><strong>Funding: </strong>WHO, the HIV Modelling Consortium within the Institute for Global Health at University College London, the Bill & Melinda Gates Foundation, the National Institute of Allergy and Infectious Diseases, the Massachusetts General Hospital Jerome and Celia Reich Endowed Scholar in HIV/AIDS Research Award, and the Steve and Deborah Gorlin Massachusetts General Hospital Research Scholars Award.</p><p><strong>Translation: </strong>For the Chichewa translation of the abstract see Supplementary Materials section.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"13 8","pages":"e1436-e1447"},"PeriodicalIF":19.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Glob Health 2015; 3: e196. 《柳叶刀全球健康》2015年更正;3: e196。
IF 19.9 1区 医学
Lancet Global Health Pub Date : 2025-08-01 Epub Date: 2025-05-21 DOI: 10.1016/S2214-109X(25)00200-1
{"title":"Correction to Lancet Glob Health 2015; 3: e196.","authors":"","doi":"10.1016/S2214-109X(25)00200-1","DOIUrl":"10.1016/S2214-109X(25)00200-1","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e1348"},"PeriodicalIF":19.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective refractive error coverage in adults: a systematic review and meta-analysis of updated estimates from population-based surveys in 76 countries modelling the path towards the 2030 global target. 成人有效屈光不正覆盖率:对76个国家基于人口的调查的最新估计进行系统回顾和荟萃分析,为实现2030年全球目标的路径建模。
IF 19.9 1区 医学
Lancet Global Health Pub Date : 2025-08-01 Epub Date: 2025-05-22 DOI: 10.1016/S2214-109X(25)00194-9
Rupert Richard Alexander Bourne, Maria Vittoria Cicinelli, David A Selby, Tabassom Sedighi, Ian H Tapply, Ian McCormick, Jost B Jonas, Mohammad H Abdianwall, Mukharram M Bikbov, Tasanee Braithwaite, Matthew J Burton, Vera Carneiro, Robert J Casson, Ching-Yu Cheng, Nathan G Congdon, Catherine Creuzot-Garcher, Leon B Ellwein, Mohammad Hassan Emamian, Akbar Fotouhi, Timothy R Fricke, David S Friedman, João M Furtado, Ronnie George, Noopur Gupta, Xiaotong Han, Hassan Hashemi, Mingguang He, Abba Hydara, Aiko Iwase, Gyulli Kazakbaeva, Rajiv B Khandekar, Rohit C Khanna, Fatima Kyari, Luisa C Luque, Srinivas Marmamula, Andreas Müller, Vinay Nangia, Kovin S Naidoo, Jacqueline Ramke, Paisan Ruamviboonsuk, Solange R Salomão, Hugh R Taylor, Yih C Tham, Fotis Topouzis, Rohit Varma, Lingam Vijaya, Ningli Wang, Ya Xing Wang, Tien Y Wong, Hua Yan, Seth R Flaxman, Stuart Keel, Serge Resnikoff
{"title":"Effective refractive error coverage in adults: a systematic review and meta-analysis of updated estimates from population-based surveys in 76 countries modelling the path towards the 2030 global target.","authors":"Rupert Richard Alexander Bourne, Maria Vittoria Cicinelli, David A Selby, Tabassom Sedighi, Ian H Tapply, Ian McCormick, Jost B Jonas, Mohammad H Abdianwall, Mukharram M Bikbov, Tasanee Braithwaite, Matthew J Burton, Vera Carneiro, Robert J Casson, Ching-Yu Cheng, Nathan G Congdon, Catherine Creuzot-Garcher, Leon B Ellwein, Mohammad Hassan Emamian, Akbar Fotouhi, Timothy R Fricke, David S Friedman, João M Furtado, Ronnie George, Noopur Gupta, Xiaotong Han, Hassan Hashemi, Mingguang He, Abba Hydara, Aiko Iwase, Gyulli Kazakbaeva, Rajiv B Khandekar, Rohit C Khanna, Fatima Kyari, Luisa C Luque, Srinivas Marmamula, Andreas Müller, Vinay Nangia, Kovin S Naidoo, Jacqueline Ramke, Paisan Ruamviboonsuk, Solange R Salomão, Hugh R Taylor, Yih C Tham, Fotis Topouzis, Rohit Varma, Lingam Vijaya, Ningli Wang, Ya Xing Wang, Tien Y Wong, Hua Yan, Seth R Flaxman, Stuart Keel, Serge Resnikoff","doi":"10.1016/S2214-109X(25)00194-9","DOIUrl":"10.1016/S2214-109X(25)00194-9","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;In 2024, WHO included effective refractive error coverage (eREC) into the results framework of the 14th General Programme of Work, which sets a road map for global health and guides WHO's work between 2025 and 2028. eREC is a measure of both the availability and quality of refractive correction in a population. This study aimed to model global and regional estimates of eREC as of 2023 and evaluate progress towards the WHO global target of a 40 percentage-point absolute increase in eREC by 2030.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;For this systematic review and meta-analysis, the Vision Loss Expert Group analysed data from 237 population-based eye surveys conducted in 76 countries since 2000, comprising 815 273 participants, to calculate eREC (met need / met need + undermet need + unmet need]) and the relative quality gap between eREC and REC ([REC - eREC] / REC × 100, where REC = [met + undermet need] / [met need + undermet need + unmet need]). An expert elicitation process was used to choose covariates for a Bayesian logistic regression model used to estimate eREC by country-age-sex grouping among adults aged 50 years and older. Country-age-sex group estimates were aggregated to provide estimates according to Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) super-regions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;Global eREC was estimated to be 65·8% (95% uncertainty interval [UI] 64·7-66·8) in 2023, 6 percentage points higher than in 2010 (eREC 59·8% [59·4-60·2]). There were marked differences in eREC between GBD super-regions in 2023, ranging from 84·0% (95% UI 83·0-85·0) in high-income countries to 28·3% (26·4-30·4) in sub-Saharan Africa. In all super-regions, eREC was lower in females than males, and decreased with increasing age among adults aged ≥50 years. Since 2000, the relative increase in eREC was 60·2% in sub-Saharan Africa, 45·7% in North Africa and the Middle East, 41·5% in southeast Asia, east Asia and Oceania, 40·3% in south Asia, 16·2% in Latin America and the Caribbean, 8·3% in central Europe, eastern Europe and central Asia, and 6·8% in the high-income super-region. The relative quality gap ranged from 2·9% to 78·3% across studies, with larger gaps characteristically in regions of lower eREC. Globally, the percentage of those with a refractive need that was undermet reduced between 2000 and 2023, from 10·0% (95% UI 9·5-10·5) to 5·3% (5·1-5·5).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Interpretation: &lt;/strong&gt;The current trajectory of improvement in eREC and the relative quality gap are insufficient to meet the 2030 target. Global efforts to equitably increase spectacle coverage, such as the WHO SPECS 2030 initiative, and to address equity failings associated with geography, age, and sex, are crucial to accelerating progress towards the 2030 targets. No region is close to achieving universal coverage.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Funding: &lt;/strong&gt;WHO, Sightsavers, The Fred Hollows Foundation, Fondation Thea, University of Heidelberg,","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e1396-e1405"},"PeriodicalIF":19.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Glob Health 2025; 13: e995–1005 《柳叶刀全球健康2025》更正;13: e995 - 1005
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-18 DOI: 10.1016/s2214-109x(25)00277-3
{"title":"Correction to Lancet Glob Health 2025; 13: e995–1005","authors":"","doi":"10.1016/s2214-109x(25)00277-3","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00277-3","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"12 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144669831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study 减少国际捐助资金对低收入和中等收入国家结核病的潜在影响:一项模拟研究
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-11 DOI: 10.1016/s2214-109x(25)00232-3
Rebecca A Clark PhD, C Finn McQuaid PhD, Alexandra S Richards PhD, Roel Bakker PhD, Tom Sumner PhD, Tomos O Prŷs-Jones PhD, Prof Rein M G J Houben PhD, Prof Richard G White PhD, Katherine C Horton PhD
{"title":"The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study","authors":"Rebecca A Clark PhD, C Finn McQuaid PhD, Alexandra S Richards PhD, Roel Bakker PhD, Tom Sumner PhD, Tomos O Prŷs-Jones PhD, Prof Rein M G J Houben PhD, Prof Richard G White PhD, Katherine C Horton PhD","doi":"10.1016/s2214-109x(25)00232-3","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00232-3","url":null,"abstract":"Tuberculosis programmes in many settings rely heavily on international donor funding. In 2025, the United States Agency for International Development (USAID) was dismantled, and other countries announced cuts to overseas development assistance. We quantified the potential epidemiological impacts on the tuberculosis burden attributable to these reductions in funding.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"7 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144622585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mpox in Africa: funding cuts and delayed global actions fuelling new epicentres. 非洲的麻疹:资金削减和延迟的全球行动助长了新的震中。
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-09 DOI: 10.1016/s2214-109x(25)00241-4
Victor Saidi Mithi
{"title":"Mpox in Africa: funding cuts and delayed global actions fuelling new epicentres.","authors":"Victor Saidi Mithi","doi":"10.1016/s2214-109x(25)00241-4","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00241-4","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"107 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144613025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995-2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023. 1995-2022年201个国家的全球、区域和国家卫生保健效率低下及其相关因素:2023年全球疾病负担研究的随机前沿荟萃分析
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-09 DOI: 10.1016/s2214-109x(25)00178-0
Amy Lastuka,Michael R Breshock,Simon I Hay,Kayla V Taylor,Stephen S Lim,Christopher J L Murray,Joseph L Dieleman
{"title":"Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995-2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023.","authors":"Amy Lastuka,Michael R Breshock,Simon I Hay,Kayla V Taylor,Stephen S Lim,Christopher J L Murray,Joseph L Dieleman","doi":"10.1016/s2214-109x(25)00178-0","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00178-0","url":null,"abstract":"BACKGROUNDAll governments face pressure to maximise the impact of their health budget. We aimed to measure health spending inefficiency for 201 countries from 1995 to 2022, estimate the cost of one additional year of healthy life, and assess contextual factors associated with health spending inefficiency.METHODSWe extracted data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2023 and the Financing Global Health 2024 project to estimate health spending inefficiency using a non-linear stochastic frontier meta-analysis model designed to assess health-adjusted life expectancy (HALE). This model produced a frontier that represents the best possible HALE for a given level of health spending. Inefficiency scores were measured as the distance between a country's HALE and the frontier at that country's level of spending. We used the slope of the frontier to estimate the cost of one additional year of healthy life, and we regressed inefficiency scores on contextual factors and policy variables to measure their association with health spending inefficiency.FINDINGSThe relationship between health spending and HALE was positive for all levels of spending, although health spending inefficiency existed in most countries. Globally, health spending inefficiency decreased from 1995 to 2019, increased considerably in 2020 and 2021 due to the COVID-19 pandemic, and recovered substantially in 2022. We found decreasing returns to additional health spending, with the cost of one additional health-adjusted life-year varying from US$92 (95% uncertainty interval 43-239) per capita for a country spending $100 per capita to $11 213 (8031-57 754) per capita for a country spending $5000 per capita. More efficient spending was associated with better governance, having a higher percentage of health expenditure from the government, infrastructure that facilitates access to and delivery of health care, and higher uptake of preventive care measures.INTERPRETATIONExpanding government-provided health-care coverage would decrease the inefficiency of the health-care system. Countries should also focus on strengthening democracy, building infrastructure, and increasing the use of, and access to, preventive care.FUNDINGBill & Melinda Gates Foundation.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"109 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144664275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PrEParing for HIV prevention among men who have sex with men in China: challenges and solutions. 中国男男性行为者预防艾滋病的准备:挑战和解决办法。
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-09 DOI: 10.1016/s2214-109x(25)00234-7
Hongbo Jiang,Huachun Zou
{"title":"PrEParing for HIV prevention among men who have sex with men in China: challenges and solutions.","authors":"Hongbo Jiang,Huachun Zou","doi":"10.1016/s2214-109x(25)00234-7","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00234-7","url":null,"abstract":"Although pre-exposure prophylaxis (PrEP) has been implemented globally, in China, engagement with the PrEP care continuum is overall low among men who have sex with men (MSM). The large population of MSM and the high proportion of PrEP-eligible individuals, coupled with low PrEP uptake and adherence, underscore the urgent need for initiatives to address barriers and facilitate uptake in this population. Based on the social ecological framework, low PrEP uptake and adherence among MSM in China can be attributed to multiple factors at the individual, interpersonal and community, and policy levels, which require a comprehensive and multifaceted approach to address. Tailored combinations of strategies need to be developed to increase PrEP awareness, acceptance, adherence, and persistence among individuals, health-care providers, and the MSM communities. Reducing stigma and discrimination towards PrEP and the MSM community is crucial to the successful implementation of PrEP. Additionally, policies that promote PrEP uptake and ensure access to appropriate regimens for eligible MSM should be in place. Solutions proposed in this Viewpoint have implications for other low-income and middle-income countries facing similar challenges against PrEP implementation.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"37 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144613021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zinc-iron interactions in the treatment of children with mild-to-moderate anaemia - Authors' reply. 锌-铁相互作用治疗儿童轻中度贫血——作者的答复。
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-07 DOI: 10.1016/s2214-109x(25)00259-1
Ranadip Chowdhury,Ravi Prakash Upadhyay,Sudarshan Mundra,Sunita Taneja,Nita Bhandari
{"title":"Zinc-iron interactions in the treatment of children with mild-to-moderate anaemia - Authors' reply.","authors":"Ranadip Chowdhury,Ravi Prakash Upadhyay,Sudarshan Mundra,Sunita Taneja,Nita Bhandari","doi":"10.1016/s2214-109x(25)00259-1","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00259-1","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"38 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144604026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zinc-iron interactions in the treatment of children with mild-to-moderate anaemia. 锌-铁相互作用治疗儿童轻中度贫血。
IF 34.3 1区 医学
Lancet Global Health Pub Date : 2025-07-07 DOI: 10.1016/s2214-109x(25)00217-7
Bingwen Eugene Fan
{"title":"Zinc-iron interactions in the treatment of children with mild-to-moderate anaemia.","authors":"Bingwen Eugene Fan","doi":"10.1016/s2214-109x(25)00217-7","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00217-7","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"107 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信